Actionable news
0
All posts from Actionable news
Actionable news in MNTA: Momenta Pharmaceuticals, Inc.,

UPDATE 1-U.S. jury sides with Amphastar over Momenta in drug patent trial

(Adds details on lawsuit, comment from Amphastar lawyer, stock prices)

By Nate Raymond

BOSTON, July 21 (Reuters) - Amphastar Pharmaceuticals Inc on Friday won a trial in a lawsuit claiming that the drugmaker through its production of a generic version of the blood-thinner Lovenox infringed a patent held by Momenta Pharmaceuticals Inc.

The verdict by a federal jury in Boston came in a long-running lawsuit pursued by Cambridge, Massachusetts-based biopharmaceutical company Momenta and its partner, Novartis AG's Sandoz unit, that sought $938 million in damages.

The 12-member jury found that while Rancho Cucamonga, California-based Amphastar had infringed Momenta's patent, jurors also found that the patent was invalid.

"We're extremely pleased with the jury verdict and that Amphastar is finally out from under this baseless lawsuit," Michael Sommer, a lawyer for Amphastar, told...


More